Last reviewed · How we verify
Management of anxiety disorders — Treatment Landscape & Competitive Intelligence
1 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Diazepam 2Mg encapsulated Tab | Diazepam 2Mg encapsulated Tab | The University of Hong Kong | Benzodiazepine | GABA-A receptor (allosteric modulator) |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- The University of Hong Kong · 1 drug in Management of anxiety disorders
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Management of anxiety disorders:
- Management of anxiety disorders treatment updates — RSS
- Management of anxiety disorders treatment updates — Atom
- Management of anxiety disorders treatment updates — JSON
Cite this brief
Drug Landscape (2026). Management of anxiety disorders — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/management-of-anxiety-disorders. Accessed 2026-06-10.
Related
- Management of anxiety disorders full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing